Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas (Q77667993)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

main subject

phase II clinical trial

1 reference

metastatic adenocarcinoma

inferred from title

1 reference

1 reference

J P Stevenson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R M Scher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R Kosierowski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S C Fox

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Simmonds

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

K S Yao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F Green

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Broom

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S Z Fields

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J B Krebs

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P J O'Dwyer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1358-1362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

cites work

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Continuous 5-fluorouracil (5FU) infusion in carcinoma of the pancreas: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

A phase II trial of topotecan in patients with previously untreated pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900053-7

7 January 2021

10.1016/S0959-8049(98)00053-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9849417%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference